ArticleCancers2025

The Prognostic Impact of Additional Molecular and Cytogenetic Abnormalities on AML Patients with NPM1- and/or FLT3-ITD Mutations Receiving Intensive Chemotherapy: Real-World Data from the Greek Registry.

Ioanna Lazana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.